Print

Aptuit, Inc. Launches "Ask an Expert" on www.aptuit.com to Assist Pharmaceutical Community  
10/4/2012 11:44:06 AM

Greenwich, CT, October 3, 2012 – Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the company has launched an interactive link, “Ask an Expert,” on its website to provide informational support to the pharmaceutical community.

Mr. Needleman stated, “The addition of ‘Ask an Expert’ is a service that extends to a broad spectrum of pharmaceutical professionals. In the course of every work day, many of them come upon issues and challenges where an expert opinion is welcomed. We anticipate that bench chemists, analytical specialists, and scientists involved in every aspect of drug discovery and drug development will turn to this valuable information source.”

It was explained that “Ask an Expert” is a simple, familiar process. The link appears on the home page of www.aptuit.com. Once accessed, a form appears which includes a dropdown menu that lists Aptuit’s range of service areas, (such as API, dosage form, preclinical, etc.) for the inquirer to select, and then enter his/her question in the provided text box.

“The professional who poses a question has the confidence that it will be answered by a true Aptuit expert in the area where he or she needs informational support. In a real sense, inquirers will establish a one-on-one contact with one of our Heads for Science and experience firsthand an example of our Hearts for Service. And, it will be accomplished within as reasonable a time as is possible,” concludes Mr. Needleman.

For more information, please contact Maria Garvey at Delfino Marketing either by phone at 914-747-1400 or by email: maria@delfino.com.

Aptuit LLC provides the most complete set of integrated early to mid-phase development services in the industry. Drug Design & Discovery, Preclinical Biosciences, Sterile Fill/Finish, Formulation Development, API Development and Manufacture, Solid State Chemistry, Clinical Sciences, Consulting and Aptuit INDiGO® (a program that accelerates drug development) are offered as stand alone or integrated services. Fully integrated drug discovery & development services are available from a single site at The Aptuit Center of Drug Discovery & Development in Verona, Italy.

Aptuit LLC maintains seven global facilities with more than 800 employees in Europe and the United States and has a partnership agreement with Laurus Labs in India. Aptuit LLC is partnered with Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors.

For more information about Aptuit, visit www.aptuit.com.


//-->